U.S FDA, CDC call for suspension of Johnson & Johnson Vaccine use

0
131
suspension of Johnson & Johnson Vaccine

After six unusual cases of blood clot recorded in six patients within 6- 13 days after taking the Johnson & Johnson vaccine, the US Center for Disease and Control and Prevention as well as the Food and Drug Administration.

Although 6.8 million doses of the vaccines were administered, all cases were noticed with women between the ages of 18 – 48. The CDC is expected to hold a meeting with the Advisory Committee on Immunization Practices (ACIP) to review the cases and discuss the potential implications of the blood clot scenarios.

Recall that the Astrazeneca vaccines also resulted in some blood clot issues which unfortunately resulted in death in some fatal cases. Investigations appear to still be underway but generally, the vaccines have been deemed safe by the WHO and other recognized health bodies.